Clinica Chimica Acta publishes original Research Communications in the field of clinical chemistry and
laboratory medicine, defined as the application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology,
and molecular biology to the study of human disease in body fluids, cells or tissues ... click here for full Aims & Scope
Clinica Chimica Acta publishes original Research Communications in the field of clinical chemistry and
laboratory medicine, defined as the application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology,
and molecular biology to the study of human disease in body fluids, cells or tissues The objective of the journal is to publish novel
information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management.
Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of
normal cells or body fluids, such as reports of experimental or clinical studies in animals, are considered in they are clearly and directly
relevant to human disease. Development and evaluation of novel analytical methodologies where applicable to clinical chemistry and laboratory
medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered.
In addition
to original Research Communications the journal publishes: (1) Short Communications-concise reports of limited scope which offer conclusive
results or document methodological advances; (2) Letters to the Editor, commenting on papers published in Clinica Chimica Acta
- these should be less than 400 words and may include 1 illustration or 1 table; (3) Invited Critical Reviews of recent central developments
in medical biochemistry and laboratory medicine; (4) case reports involving interesting or novel clinical laboratory data; (5) Newsletters
of Scientific Societies; (6) Meeting announcements.
Typescripts submitted to Clinica Chimica Acta should not have been
published previously and should not be under consideration for publication elsewhere. The agreement of all named authors to the submission
must be affirmed. Relevant ethical approval must be noted for investigations involving human or animal subjects. Authors are invited
to consult any member of the Editorial Board, if in doubt about any aspect of scope, format or content of a proposed paper.
Hide Aims & Scope
Editors-in-Chief:
J. Delanghe
A.H.B. Wu
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company